Kraig Biocraft Laboratories, Inc - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - November 13, 2018

Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Kraig Biocraft Laboratories, IncEx311.htm
10-Q - PRIMARY DOCUMENT - Kraig Biocraft Laboratories, Inckblb_10q.htm
 
 
EXHIBIT 32.1
 
CERTIFICATIOND PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Kim Thompson, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
 
 
1.
The Quarterly Report on Form 10-Q of Kraig Biocraft Laboratories, Inc. (the “Company”) for the period ended September 30, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (U.S.C. 78m or 78o(d)); and
 
 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: November 13, 2018
By:
  /s/ Kim Thompson
 
 
Kim Thompson
 
 
Chief Executive Officer
(Principal Executive Officer)
 
Date: November 13, 2018
 
 
 
By:
  /s/ Kim Thompson
 
 
Kim Thompson
 
 
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of a separate disclosure document.
 

Kraig Biocraft Laboratories, Inc Reports